Skip to main content
Equibles
MWAI logo

MWAI · MedWellAI, Inc.

Track MWAI — free

Use MWAI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.37 +0.10 (+37.09%) At close · Sep 2
Rebalance outlook locked
Going-concern doubt — flagged May 5, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Historically, the Company has reported recurring net losses from operations and used net cash in operating activities. As of March 31, 2026, the Company's current liabilities exceeded its current assets by $7,612,521 and the Company had an accumulated deficit of $89,853,514. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed May 5, 2026
Customer concentration — top customer 96% of revenue

One customer — 96% of revenue (the year ended June 30, 2025)

“One customer generated approximately 96% of our revenue during the year ended June 30, 2025.”

One customer — 96% of revenue (the year ended June 30, 2025)

“During the year ended June 30, 2025 we had a concentration of revenue to one customer representing approximately 96% of our total revenue.”
View the 10-K filed Sep 30, 2025
Market Cap
$2.42M
Shares
6.54M

MWAI metrics

57 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.37
Market cap
$2.42M

Price action

19 metrics
Price change (1W)
+15.6%
Price change (30D)
+5.7%
Price change (3M)
+37.0%
Price change (6M)
-18.0%
Price change (YTD)
-26.0%
Price change (1Y)
-28.8%
Trailing year
Price change (5Y)
—
52-week high
$0.77
52-week low
$0.20
Change from 52-week high
-51.6%
Change from 52-week low
+84.1%
Annualized volatility
205.5%
Beta
-0.1
RSI (14D)
56.1
Price vs SMA 50
+15.1%
Price vs SMA 200
-21.1%
Avg volume (3M)
4,849
Relative volume
0.3
Average dollar volume
$1,529

Company

3 metrics
Sector
Financial Services
Industry
Capital Markets
Shares outstanding
6.54M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.7×
reciprocal yield 59.2%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-92.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-136.1%
Trailing 12 months
Net margin
-155.3%
Gross profit (TTM)
−$2.62M
Operating profit (TTM)
−$1.95M
Net income (TTM)
−$2.23M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$6.21

Growth

11 metrics
Revenue growth YoY
+119.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.43M
Trailing 12 months
EPS growth YoY
-1,100.0%
Shares change YoY
-67.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-55.1%
Revenue CAGR (5Y)
+5.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-691.5%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
−$1.92M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-36.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$130,028
Total assets
$321,787
Total debt
$327,981

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$372,027
Capital expenditures (TTM)
$0
R&D (TTM)
$1,632
SG&A (TTM)
$30
Stock compensation (TTM)
$155,958
R&D / revenue
—
Stock compensation / revenue
10.9%

Ownership (13F)

3 metrics
13F filers
1
13F filer change QoQ
-12
Institutional ownership
0.3%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 4.2 days to cover
Days to cover
4.2d
Short-squeeze score
50 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1520118 CUSIP 45826P309 Visit website